Data from European Academy of Allergy and Clinical Immunology (EAACI) - Curated by EPG Health - Date added 29 June 2018
This year’s EAACI Congress took place in Munich, Germany from 26–30 May 2018, and is the world's largest and most influential allergy, asthma and clinical immunology meeting. Organised by the European Academy of Allergy and Clinical Immunology (EAACI), Europe’s largest medical association in the field of allergy and clinical immunology, EAACI 2018 offered a unique opportunity to learn about the latest breakthroughs and discoveries. The theme of this year’s EAACI congress was ‘innovations for allergy’, reflective of Munich’s global scientific and technological status as this year’s host city, facilitating debate around novel solutions to the widespread and growing allergy epidemic.
EPG Health conducted a sponsored symposium on Sunday 27 May entitled 'Global perspectives on chronic spontaneous urticaria (CSU) management: international recommendations vs. local practice'. Video presentations from the event are now available to watch at the CSU Knowledge Centre.
Our 'EAACI hot topics' series discusses the latest breakthroughs made in clinical immunology, evaluating advancements in smart technologies, allergen specific immunotherapy, hereditary angioedema and urticaria.
Take a look at our previous articles:
- Allergen specific immunotherapy (AIT) – Does AIT have a place in modern allergy treatment?
- Allergy management and the smart technology revolution – Do smart technologies have a role to play in the future of allergy management?